APA (7th ed.) Citation

Gong, K., Huang, Y., Zheng, Y., Zhu, Y., Hao, W., & Shi, K. (2024). Preclinical efficacy of CBR-5884 against epithelial ovarian cancer cells by targeting the serine synthesis pathway. Discover Oncology, 15(1), . https://doi.org/10.1007/s12672-024-01013-0

Chicago Style (17th ed.) Citation

Gong, Kunxiang, Yinger Huang, Yanqin Zheng, Yinfu Zhu, Wenbo Hao, and Kun Shi. "Preclinical Efficacy of CBR-5884 Against Epithelial Ovarian Cancer Cells by Targeting the Serine Synthesis Pathway." Discover Oncology 15, no. 1 (2024). https://doi.org/10.1007/s12672-024-01013-0.

MLA (9th ed.) Citation

Gong, Kunxiang, et al. "Preclinical Efficacy of CBR-5884 Against Epithelial Ovarian Cancer Cells by Targeting the Serine Synthesis Pathway." Discover Oncology, vol. 15, no. 1, 2024, https://doi.org/10.1007/s12672-024-01013-0.